Skip to content
10-Q

Quarterly Report

Hoth Therapeutics, Inc. RKTO

0001213900-25-109220

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 11, 2025 15.51M sh
Stock Issued Q3 2025 · Sep 30, 2025 1.4M sh
Stock Issued Q3 2025 · Jun 30, 2025 66.1K sh
Shares Diluted Q3 2025 · Sep 30, 2025 13.79M sh
Shares Diluted Q3 2025 · Sep 30, 2025 13.2M sh
Shares Diluted Q3 2025 · Sep 30, 2024 6.9M sh
Shares Diluted Q3 2025 · Sep 30, 2024 6.06M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$7.65M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$4.95M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $7.85M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $7.04M
Stockholders Equity Q3 2025 · Sep 30, 2025 $8.23M
Stockholders Equity Q3 2025 · Jun 30, 2025 $9.74M
Stockholders Equity Q3 2025 · Mar 31, 2025 $11.54M
Stockholders Equity Q3 2025 · Dec 31, 2024 $6.88M
Stockholders Equity restated Q3 2025 · Sep 30, 2024 $7.94M
Stockholders Equity restated Q3 2025 · Jun 30, 2024 $9.88M
Stockholders Equity restated Q3 2025 · Mar 31, 2024 $8.45M
Stockholders Equity restated Q3 2025 · Dec 31, 2023 $9.54M
Current Liabilities Q3 2025 · Sep 30, 2025 $1.01M
Current Liabilities Q3 2025 · Dec 31, 2024 $831.2K
Total Liabilities Q3 2025 · Sep 30, 2025 $1.01M
Total Liabilities Q3 2025 · Dec 31, 2024 $833.91K
Current Assets Q3 2025 · Sep 30, 2025 $8.92M
Current Assets Q3 2025 · Dec 31, 2024 $7.64M
Total Assets Q3 2025 · Sep 30, 2025 $9.24M
Total Assets Q3 2025 · Dec 31, 2024 $7.71M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.30
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.74
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$0.32
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$1.00
Eps Basic Q3 2025 · Sep 30, 2025 −$0.30
Eps Basic Q3 2025 · Sep 30, 2025 −$0.74
Eps Basic restated Q3 2025 · Sep 30, 2024 −$0.32
Eps Basic restated Q3 2025 · Sep 30, 2024 −$1.00
Rd Expense Q3 2025 · Sep 30, 2025 $1.63M
Rd Expense Q3 2025 · Sep 30, 2025 $4.63M
Rd Expense restated Q3 2025 · Sep 30, 2024 $994.47K
Rd Expense restated Q3 2025 · Sep 30, 2024 $2.21M
Net Income Q3 2025 · Sep 30, 2025 −$4.11M
Net Income Q3 2025 · Sep 30, 2025 −$9.78M
Net Income Q3 2025 · Jun 30, 2025 −$2.2M
Net Income Q3 2025 · Mar 31, 2025 −$3.48M
Net Income restated Q3 2025 · Sep 30, 2024 −$2.23M
Net Income restated Q3 2025 · Sep 30, 2024 −$6.09M
Net Income restated Q3 2025 · Jun 30, 2024 −$1.71M
Net Income restated Q3 2025 · Mar 31, 2024 −$2.15M
Operating Income Q3 2025 · Sep 30, 2025 −$4.08M
Operating Income Q3 2025 · Sep 30, 2025 −$9.76M
Operating Income restated Q3 2025 · Sep 30, 2024 −$2.23M
Operating Income restated Q3 2025 · Sep 30, 2024 −$6.11M